Centiva Capital, LP Codexis, Inc. Transaction History
Centiva Capital, LP
- $4.65 Billion
- Q4 2024
A detailed history of Centiva Capital, LP transactions in Codexis, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 36,329 shares of CDXS stock, worth $154,761. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,329Holding current value
$154,761% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
60.6MCall Options Held
68.5KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.84MShares$37.7 Million8.29% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$34.5 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$19 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$12.8 Million1.53% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $279M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...